VERU
USDVeru Inc. Common Stock
$0.653-0.007 (-1.061%)
实时价格
Healthcare
生物技术
美国
价格图表
Loading Chart...
关键指标
市场指标
开盘价
$0.660
最高价
$0.685
最低价
$0.612
成交量
1.69M
公司基本面
市值
95.7M
所属行业
生物技术
国家/地区
United States
交易统计
平均成交量
2.33M
交易所
NCM
货币
USD
52周价格范围
最低价 $0.45当前价 $0.653最高价 $1.42
相关新闻
GlobeNewswire
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and
查看更多
GlobeNewswire
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
--Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of
查看更多
